In vitro and in vivo antifungal activities of T-2307, a novel arylamidine. - Wikidata - wikimedia - TriplyDB

In vitro and in vivo antifungal activities of T-2307, a novel arylamidine.

In vitro and in vivo antifungal activities of T-2307, a novel arylamidine.

http://www.wikidata.org/entity/Q36538739

about

Emerging drugs and vaccines for candidemia Pharmacokinetics and pharmacodynamics of antifungals in children: clinical implications Structural aspects of intermolecular interactions in the solid state of 1,4-dibenzylpiperazines bearing nitrile or amidine groups T-2307 shows efficacy in a murine model of Candida glabrata infection despite in vitro trailing growth phenomena.The novel arylamidine T-2307 maintains in vitro and in vivo activity against echinocandin-resistant Candida albicans.Efficacy of oral E1210, a new broad-spectrum antifungal with a novel mechanism of action, in murine models of candidiasis, aspergillosis, and fusariosis.In vitro and in vivo antimalarial activities of T-2307, a novel arylamidine The novel arylamidine T-2307 demonstrates in vitro and in vivo activity against echinocandin-resistant Candida glabrata A complex game of hide and seek: the search for new antifungals Synthesis and SAR of alkanediamide-linked bisbenzamidines with anti-trypanosomal and anti-pneumocystis activity.Human fungal pathogen Candida albicans in the postgenomic era: an overview.Addressing current medical needs in invasive fungal infection prevention and treatment with new antifungal agents, strategies and formulations.Antifungals: Mechanism of Action and Drug Resistance.Systemic Antifungal Agents: Current Status and Projected Future Developments.The anti-Aspergillus drug pipeline: Is the glass half full or empty?The antifungal pipeline: a reality check.Echinocandins in antifungal pharmacotherapy.Novel Agents and Drug Targets to Meet the Challenges of Resistant Fungi.In vitro and in vivo antifungal activities of T-2307, a novel arylamidine, against Cryptococcus gattii: an emerging fungal pathogen.T-2307, a novel arylamidine, is transported into Candida albicans by a high-affinity spermine and spermidine carrier regulated by Agp2.T-2307 causes collapse of mitochondrial membrane potential in yeast.Antifungal resistance: current trends and future strategies to combat.Uptake of T-2307, a novel arylamidine, in Candida albicans.Newer antifungal agents.New Horizons in Antifungal Therapy.Dermatophyte Resistance to Antifungal Drugs: Mechanisms and Prospectus.

P2860

Q26828993-4A5D175E-1263-46D2-B4EE-B9B071DC0BA1 Q27025299-1F6E10FB-CAB5-4FC5-A357-AA9B3AF40A89 Q30856957-6FD78B0A-3AE5-4710-96A1-6B65BD1119FD Q34108719-7E620AB9-F04F-4726-895F-01FAEA29C0B0 Q35105818-17624263-C280-432E-AEDA-420152DC8B15 Q35270948-6F84CEA8-A418-4E91-BA49-4AA1FDBEF3E1 Q35867504-274C205F-6E00-4BE4-A673-2C4C1BBD8E12 Q36551326-EBE865D2-F950-4AC9-86EA-9356B204A353 Q37344546-8504EF7D-36AF-4DEA-8762-E0614FF13E4B Q37366806-44E9CE90-8A4C-481D-B49C-7BEA313213B6 Q37557700-2DB776BD-B56A-40BC-A3D5-9A9C381F7946 Q37918556-738086B9-3258-49A6-AB5C-1176CDDDCD8E Q38684281-E9B8B1D0-A049-46D3-906B-34E148C91761 Q38796140-7F4D4FED-7379-426A-9206-7C46F306A07C Q38937577-35B779DF-3227-45AB-8679-C20A9F8BFE85 Q39299949-DE7C1AD2-4100-4838-A364-AB51CABBE8EE Q39458862-1C9F1645-2091-421D-B103-D17FEA8C5233 Q40045666-12FF72D6-ACD3-4BBB-ACF3-A1020515926A Q40332083-A460AC7C-8358-4D7C-B94B-6ED02192546E Q40709545-BFAD2EE5-F0CC-4C86-B182-CFA083520474 Q41571211-673FF2F6-1E33-45A6-93FD-A555E920B5CE Q41632930-943BF07B-4773-499A-B244-144DF3EF73A3 Q43049773-D13D89F5-5590-4E0A-85E5-6F0C50085C2B Q44855715-B9006F73-9460-483F-AED9-AE5B163EB558 Q48149179-7B07E828-15AD-4915-A929-A70F3768BFB5 Q55098668-1CC3276A-9C66-473C-AEAB-3FAF7EC934E6

P2860

In vitro and in vivo antifungal activities of T-2307, a novel arylamidine.

http://www.wikidata.org/entity/Q36538739

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

In vitro and in vivo antifungal activities of T-2307, a novel arylamidine.

@ast

In vitro and in vivo antifungal activities of T-2307, a novel arylamidine.

@en

type

label

In vitro and in vivo antifungal activities of T-2307, a novel arylamidine.

@ast

In vitro and in vivo antifungal activities of T-2307, a novel arylamidine.

@en

prefLabel

In vitro and in vivo antifungal activities of T-2307, a novel arylamidine.

@ast

In vitro and in vivo antifungal activities of T-2307, a novel arylamidine.

@en

P1433

Q36538739-4C7BD718-BD69-46FC-8164-EFCC1D6F23F6

P1476

Q36538739-EE0F6D95-9044-4A23-9469-72748902B4E2

P2093

Q36538739-2FEE9F07-CB5A-4E31-8357-2EBE88ADFB62

Q36538739-49AEF0AA-6703-4139-8928-8C18E7545BD8

Q36538739-88F08132-F52C-4E32-8DDD-CA6C490F969A

Q36538739-A2870ABF-EE79-496D-95FD-79529983F07D

Q36538739-AD20F6B8-F456-49D2-ABB3-05029FA90BD6

Q36538739-CDCB71E5-9421-44A6-A176-296B6A4AC3F4

Q36538739-E50E86C4-AF76-48A7-A1AB-DAC63384D990

Q36538739-F079AEB0-AA71-4E4A-8200-4D7C0028CF90

Q36538739-F985F420-911C-4C11-B685-0CB0E65B20D6

P2860

Q36538739-280AD3D5-838E-4F39-9B5D-7BF5857CF6FB

Q36538739-2D9B88A4-1248-4EE3-A51F-281D95D0DEC8

Q36538739-37621183-C26E-40FA-A97D-6E859FCD1E90

Q36538739-3819D705-BE5A-4AAF-A9D7-34C9201BC179

Q36538739-38DC0D9E-23C6-4772-9872-BF2208E53825

Q36538739-4C702A97-2226-40A0-8C53-7424D83D73D5

Q36538739-4EDF1E7A-8DBF-45DA-8C77-EBBFA4E74208

Q36538739-569149C7-DB6A-4CC3-8F13-4C0739DF73C6

Q36538739-80135EC2-4E24-4CCB-AD5A-D092D9955A74

Q36538739-85EF7B2F-0956-4779-9412-858ADA392402

P304

Q36538739-E2A9964A-DCD2-4870-A2AF-ED3C54DD2CCE

P31

Q36538739-8883D46D-137E-4636-BF5D-77330AA14431

P356

Q36538739-6357A87B-334C-45E0-93C2-07D9118212C7

P407

Q36538739-32C8F8C0-455C-48C9-BE49-5897B9325AAE

P433

Q36538739-799FF3E5-32DC-4AF7-889B-84DA162CB3B7

P478

Q36538739-3D430186-4659-4997-8CD4-3D488F7E334D

P577

Q36538739-8321C7EA-6119-4E9A-99FF-428DD851214E

P5875

Q36538739-18B6EFDB-4787-4DC2-A138-57E9D9DAD28B

P698

Q36538739-E0F5EBCA-10C4-4DA3-A359-0C0FB673CC0B

P932

Q36538739-08BBDE1E-1F4B-4214-B564-750F2D7E13A5

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

In vitro and in vivo antifungal activities of T-2307, a novel arylamidine.

@en

P2093

Akiko Kimura

http://www.w3.org/2001/XMLSchema#string

Eio Yamada

http://www.w3.org/2001/XMLSchema#string

Hirokazu Narita

http://www.w3.org/2001/XMLSchema#string

Hiroshi Nishikawa

http://www.w3.org/2001/XMLSchema#string

Junichi Mitsuyama

http://www.w3.org/2001/XMLSchema#string

Kyoko Hashimoto

http://www.w3.org/2001/XMLSchema#string

Makoto Kaeriyama

http://www.w3.org/2001/XMLSchema#string

Nobuhiko Nomura

http://www.w3.org/2001/XMLSchema#string

Yozo Todo

http://www.w3.org/2001/XMLSchema#string

P2860

Crystal structure of d(CGCGAATTCGCG) complexed with propamidine, a short-chain homologue of the drug pentamidine

Inhibition of topoisomerases from Pneumocystis carinii by aromatic dicationic molecules

Analogues of 1,5-bis(4-amidinophenoxy)pentane (pentamidine) in the treatment of experimental Pneumocystis carinii pneumonia

Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of disseminated candidiasis and aspergillosis

Echinocandin antifungal drugs

International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobia

Pentamidine inhibition of group I intron splicing in Candida albicans correlates with growth inhibition.

Pentamidine inhibits mitochondrial intron splicing and translation in Saccharomyces cerevisiae.

DB-289 Immtech International.

Further standardization of broth microdilution methodology for in vitro susceptibility testing of caspofungin against Candida species by use of an international collection of more than 3,000 clinical isolates.

P304

1318-1324

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.01159-07

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P577

2008-01-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5625041

http://www.w3.org/2001/XMLSchema#string

P698

18227186

http://www.w3.org/2001/XMLSchema#string

P932

2292552

http://www.w3.org/2001/XMLSchema#string